Seeking artificial kidney innovations from the cellular, tissue, and organ bioengineering communities.
This Competition solicits applications that support innovations in regenerative medicine, cellular engineering, tissue engineering, systems biology, and synthetic biology to either advance the development of a bioartificial kidney prototype or create enabling tools that address key challenges for developing an artificial kidney platform. With the Artificial Kidney Prize, HHS and ASN intend to stimulate the market for further kidney health innovation, drawing greater participation and capital.
People with kidney diseases need kidney replacement therapies that increase survival and improve quality of life. Innovation is urgently needed – but also incredibly difficult: a functioning kidney is built from over 26 different cell types that seamlessly integrate to maintain homeostasis. KidneyX aims to increase the options for treating people with kidney diseases—including the creation of a bioartificial kidney. The first phase of the Artificial Kidney Prize (awarded in Fall 2021) sought solutions to enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys. This phase of the Artificial Kidney Prize aims to accelerate the development of an artificial kidney from the regenerative medicine, cellular engineering, tissue engineering, systems biology, and synthetic biology communities.
Learn More about KidneyX and the Artificial Kidney Prize Phase 2